Sinusoidal obstruction syndrome historical perspective

Jump to navigation Jump to search

Sinusoidal obstruction syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sinusoidal obstruction syndrome from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sinusoidal obstruction syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sinusoidal obstruction syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sinusoidal obstruction syndrome historical perspective

CDC on Sinusoidal obstruction syndrome historical perspective

Sinusoidal obstruction syndrome historical perspective in the news

Blogs on Sinusoidal obstruction syndrome historical perspective

Directions to Hospitals Treating Sinusoidal obstruction syndrome

Risk calculators and risk factors for Sinusoidal obstruction syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Historical Perspective

  • This section should include the name of the disease in the first sentence, and give a brief description of the important aspects of the information that is relayed in the rest of the page.
  • For an example of the overview section of the historical perspective page, click here.

Template

  • First Sentence:
[Disease name] was first discovered by [scientist] in [year] during/following [event].
OR
[Disease name] was first described by [scientist] in [year].
  • Examples:
Example 1:Shigella was first discovered by Dr. Kiyoshi Shiga following a bacillary dysentery outbreak in Japan in 1896.
Example 2: Melanoma was first described by Hippocrates in the 5th century BC.


  • Additional Sentences:
Additional Sentence 1: In [year], the first [event] occurred/was first reported following/during [event].
Additional Sentence 2: In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].
Additional Sentence 3: There have been several outbreaks of [disease] which are summarized below.
Additional Sentence 4: [Disease name] was first described in [year] by [scientist].
Additional Sentence 5: [Risk factor or cause] was first discovered to be associated with [disease] in [year].
Additional Sentence 6: In [year], [scientist] was the first to discover the association between [risk factor] and development of [disease].
Additional Sentence 7: In [year], [gene] mutations were first identified in the pathogenesis of [disease].
  • Examples:
Example 1: In 1918, the first major human influenza pandemic occurred.
Example 2: In 2003, human-to-human transmission of avian influenza was first reported during the influenza A H5N1 outbreaks in Southeast and Central Asia.
Example 3: In 1978, the first cell-cytotoxicity assay was developed by Te-Wen Chang to diagnose C. difficile infection based on fecal toxins A and B.
Example 4: There have been several outbreaks of avian influenza which are summarized below.
Example 5: In 1956, Henry Lancaster, an Australian mathematician, was the first to discover the association between UV radiation exposure and development of melanoma.
Example 6: In 2003, BRAF mutations were first identified in the pathogenesis of melanoma.

References

Template:WS Template:WH